These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 23156085)
61. [Modern methods of energy homeostasis correction in elderly patients]. Rumiantseva SA; Silina EV; Tsukurova LA; Stupin VA; Chichanovskaia LV; Nazarov MV; Kovalenko AL; Kabaeva EN Adv Gerontol; 2014; 27(4):746-52. PubMed ID: 25946854 [TBL] [Abstract][Full Text] [Related]
62. [The study of the effectiveness of drug prevention mechanisms of cardiovascular aging by cytoflavin]. Kartashova EA; Romantsov MG; Sarvilina IV Adv Gerontol; 2014; 27(4):737-45. PubMed ID: 25946853 [TBL] [Abstract][Full Text] [Related]
63. Early predictive blood markers of hemorrhagic stroke - influence of cytoflavin therapy. Silina EV; Rumyantceva SA; Stupin VA; Parfenov VA; Bolevich SB Can J Physiol Pharmacol; 2021 Jan; 99(1):72-79. PubMed ID: 32910863 [TBL] [Abstract][Full Text] [Related]
64. [Protective effect of cytoflavin and its components in mice with acute alloxan intoxication]. Volchegorskiĭ IA; Rassokhina LM; Ermakova SG; Miroshnichenko IIu Eksp Klin Farmakol; 2013; 76(4):26-31. PubMed ID: 23762986 [TBL] [Abstract][Full Text] [Related]
65. [Gerontological trends of contemporary forms of alcohol dependence. Approaches to full compensation and rehabilitation]. Kovalenko AL; Sosin IK; D'iachenko TV; Chuev IuF; Goncharova EIu; Skalyga IM; Kasparevich AIu; Krivosheeva MD Adv Gerontol; 2014; 27(3):553-9. PubMed ID: 25827006 [TBL] [Abstract][Full Text] [Related]
66. [Cytoflavin in the treatment of preschool and early school age children with the consequences of perinatal hypoxic brain damages]. Lavrick SY; Shprakh VV; Domitrak SV; Borisov AS Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(10):34-37. PubMed ID: 27845313 [TBL] [Abstract][Full Text] [Related]
67. [Efficacy of the complex drug cytoflavin in the treatment of consequences of mild brain injury]. Skoromets AA; Pugacheva EL Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(3):31-6. PubMed ID: 20517223 [TBL] [Abstract][Full Text] [Related]
68. [Meta-analytic assessment of parenteral cytoflavin effectiveness in different neurologic disorders]. Mazin PV; Sheshunov IV; Mazina NK Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(3):28-39. PubMed ID: 28399094 [TBL] [Abstract][Full Text] [Related]
69. [Antioxidant protection in surgical correction of inborn heart disease with the use of artificial circulation]. Bakhareva IuA; Nadiradze ZZ Khirurgiia (Mosk); 2011; (5):61-5. PubMed ID: 21666584 [No Abstract] [Full Text] [Related]
70. [Dynamics of indicators of the functional state of the central nervous system in Navy operators treated with cytoflavin after a long working cycle]. Parfenov SA; Belov VG; Parfenov YA Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(8):55-58. PubMed ID: 28884718 [TBL] [Abstract][Full Text] [Related]
71. [Efficacy of cytoflavin in the treatment of chronic cerebral ischemia]. Suslina ZA; Klocheva EG; Piradov MA; Rumiantseva SA; Romantsov MG; Kovalenko AL Klin Med (Mosk); 2010; 88(3):50-3. PubMed ID: 20608066 [TBL] [Abstract][Full Text] [Related]
72. [Cytoflavine effect on exudative-destructive manifestations of lung tuberculosis in children and teenagers]. Volchegorskiĭ IA; Novoselov PN; Denisenko IA Eksp Klin Farmakol; 2009; 72(4):20-4. PubMed ID: 19803365 [TBL] [Abstract][Full Text] [Related]
73. [Effect of the Cytoflavin on the distal polyneuropathy severity in patients with diabetic foot syndrome with arteries mediacalcinosis]. Skripko VD; Kovalenko AL; Zaplutanov VA Khirurgiia (Mosk); 2017; (8):75-78. PubMed ID: 28805783 [TBL] [Abstract][Full Text] [Related]
74. [Comparative experimental study of antioxidant efficiency in treatment of acute pancreatitis]. Kliuĭko DA; Korik VE; Zhidkov SA Eksp Klin Farmakol; 2011; 74(9):11-5. PubMed ID: 22164440 [TBL] [Abstract][Full Text] [Related]
75. [The use of cytoflavin for the treatment of chronic brucellosis]. Shul'diakov AA; Liapina EP; Soboleva LA; Reshetnikov AA; Zubareva EV; Trubetskov AD; Anashchenko AV; Evdokimov AV Klin Med (Mosk); 2011; 89(2):56-8. PubMed ID: 21574446 [TBL] [Abstract][Full Text] [Related]
76. [The structure of psychopathology associated with addictive disorders, against alcohol addiction and the possibility of it's neurometabolic correction in the elderly]. Belov VG; Parfenov IuA; Zaplutanov VA; Khaĭrutdinov DR Adv Gerontol; 2013; 26(4):696-701. PubMed ID: 24738262 [TBL] [Abstract][Full Text] [Related]
77. [SUBSTANTIATION OF INDICATIONS FOR BIOFEEDBACK THERAPY AND CYTOFLAVIN APPLICATION IN TREATMENT OF OSTEOCHONDROSIS NEUROLOGICAL COMPLICATIONS IN ELDERLY PATIENTS]. Parfenov Y; Vasilevskaya M; Parfenov S; Sapozhnikov K; Kovalenko A; Zaplutanov V Georgian Med News; 2018 Oct; (283):89-96. PubMed ID: 30516501 [TBL] [Abstract][Full Text] [Related]
78. [Treatment of alcohol addiction syndrome with cytoflavin]. Belov VG; Parfenov IuA; Okovityĭ SV Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(6 Pt 2):54-7. PubMed ID: 23887469 [TBL] [Abstract][Full Text] [Related]
79. [Antioxidant protection as a component of anesthetic management cancer patients]. Tumanian SV; Ivanova LG Khirurgiia (Mosk); 2011; (6):66-9. PubMed ID: 21716223 [No Abstract] [Full Text] [Related]
80. [The efficacy of metabolic treatment in the early recovery period of patients with ischemic stroke]. Poltavskaya TS; Bazhenov VA; Volojanin AV Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(3. Vyp. 2):49-53. PubMed ID: 32307430 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]